Table 1 Attributes and levels included in the discrete choice experiment (DCE).
Attribute | Attribute description | Number of levels | Level description |
|---|---|---|---|
Location | Location on the body where LA-PrEP will be injected | 4 | Upper arm (L3) |
Thigh (L2) | |||
Gluteal (L1) | |||
No injection (opt-out) (L0) (omitted category) | |||
Duration | Length of time for which the injectable LA-PrEP dosage would provide protection against HIV infection | 4 | 12 months (L3) |
6 months (L2) | |||
2 months (L1) | |||
0 months (opt-out) (L0) (omitted category) | |||
Provider type | Type of care provider administering LA-PrEP | 4 | HIV care provider (L3) |
Primary care provider (L2) | |||
Gender-affirming care provider (L1) | |||
No provider (opt-out) (L0) (omitted category) | |||
Site | Site where LA-PrEP program is offered | 4 | HIV care clinic (L3) |
Primary care clinic (L2) | |||
Gender-affirming care clinic (L1) | |||
No site (opt-out) (L0) (omitted category) | |||
Hormone | Type of gender-affirming hormone prescription given at LA-PrEP appointment | 4 | Injectable and oral hormone co-prescription (L3) |
Injectable hormone co-prescription (L2) | |||
Oral hormone co-prescription (L1) | |||
No co-prescription (opt-out) (L0) (omitted category) |
